Skip to content
← Full study record

NCT00513292 · MORE INFO

Limitations, agreements, and source contact

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery · Source last updated 2019-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
abuzdar@mdanderson.org
organization
University of Texas MD Anderson Cancer Center, Houston, TX, USA
phone
713-792-2817
title
Aman U. Buzdar, MD
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
abuzdar@mdanderson.org
organization
University of Texas MD Anderson Cancer Center, Houston, TX, USA
phone
713-792-2817
title
Aman U. Buzdar, MD

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice